Home
Storia in 3 fonti
Chime almost died in 2016, turned down by 100 VCs — today it IPO’d at $14.5B | TechCrunch
In 2016 when Chime desperately needed cash, over 100 VCs said no. One seed VC, took a chance and saved the company, co-founder Ryan King recalls.
- ·
techcrunch.com
Vijay Pande, founding partner of a16z bio and health strategy, steps down | TechCrunch
Since its founding in 2014, a16z Bio+ Health has raised four funds of nearly $3 billion each, including a $1.5 billion fund that closed in 2022.
- ·
cnbc.com
Chime's IPO will test public market appetite for fintech as companies line up to exit
After a multi-year IPO freeze, fintech companies like Chime are entering the public market with slashed valuations and tempered expectations.
- ·
Chime almost died in 2016, turned down by 100 VCs — today it IPO’d at $14.5B | TechCrunch
In 2016 when Chime desperately needed cash, over 100 VCs said no. One seed VC, took a chance and saved the company, co-founder Ryan King recalls.
- ·
After a string of successes, early-stage fund Felicis raises fresh $900M | TechCrunch
Lately, Felicis, like most VCs, has been all over AI. Its portfolio now includes, for example, Browser Use, Poolside, Runway, and Supabase.
- ·
fortune.com
Chime rises 37% as the IPO market opens up
Chime raises $864 mln with IPO, but management doesn’t sell shares.
- ·
Iconiq VCs spent two years courting Chime and the firm isn't selling its stake | TechCrunch
Iconiq pursued Chime because the founders were focused, and didn’t get distracted by "shiny new objects."